Insider Transactions in Q4 2022 at Syndax Pharmaceuticals Inc (SNDX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2022
|
Peter Ordentlich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
17,200
-98.48%
|
$430,000
$25.05 P/Share
|
|
Dec 02
2022
|
Peter Ordentlich Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,200
+49.62%
|
$103,200
$6.38 P/Share
|
|
Dec 01
2022
|
Peter Ordentlich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,800
-93.63%
|
$195,000
$25.01 P/Share
|
|
Dec 01
2022
|
Peter Ordentlich Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,800
+48.36%
|
$46,800
$6.37 P/Share
|
|
Oct 06
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,231
-47.89%
|
$405,775
$25.29 P/Share
|
|
Oct 06
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,231
+32.38%
|
$129,848
$8.77 P/Share
|
|
Oct 06
2022
|
Keith Katkin |
SELL
Open market or private sale
|
Direct |
29,899
-30.77%
|
$747,475
$25.9 P/Share
|
|
Oct 06
2022
|
Keith Katkin |
BUY
Exercise of conversion of derivative security
|
Direct |
29,899
+23.2%
|
$239,192
$8.41 P/Share
|
|
Oct 04
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,280
-6.76%
|
$32,000
$25.02 P/Share
|
|
Oct 04
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,280
+6.33%
|
$10,240
$8.77 P/Share
|
|
Oct 04
2022
|
Keith Katkin |
SELL
Open market or private sale
|
Direct |
360
-0.56%
|
$9,000
$25.0 P/Share
|
|
Oct 04
2022
|
Keith Katkin |
BUY
Exercise of conversion of derivative security
|
Direct |
360
+0.56%
|
$2,880
$8.41 P/Share
|
|
Oct 03
2022
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,883
-14.03%
|
$72,075
$25.01 P/Share
|
|
Oct 03
2022
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,883
+12.31%
|
$23,064
$8.77 P/Share
|
|
Oct 03
2022
|
Keith Katkin |
SELL
Open market or private sale
|
Direct |
180
-0.28%
|
$4,500
$25.0 P/Share
|
|
Oct 03
2022
|
Keith Katkin |
BUY
Exercise of conversion of derivative security
|
Direct |
180
+0.28%
|
$1,440
$8.41 P/Share
|